Metabolomics and Metabolic Diseases: Where Do We Stand?

Journal Article (Journal Article;Review)

Metabolomics, or the comprehensive profiling of small molecule metabolites in cells, tissues, or whole organisms, has undergone a rapid technological evolution in the past two decades. These advances have led to the application of metabolomics to defining predictive biomarkers for incident cardiometabolic diseases and, increasingly, as a blueprint for understanding those diseases' pathophysiologic mechanisms. Progress in this area and challenges for the future are reviewed here.

Full Text

Duke Authors

Cited Authors

  • Newgard, CB

Published Date

  • January 10, 2017

Published In

Volume / Issue

  • 25 / 1

Start / End Page

  • 43 - 56

PubMed ID

  • 28094011

Pubmed Central ID

  • PMC5245686

Electronic International Standard Serial Number (EISSN)

  • 1932-7420

Digital Object Identifier (DOI)

  • 10.1016/j.cmet.2016.09.018

Language

  • eng

Conference Location

  • United States